Company ProfilePremium

Aphria Inc

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aphria Inc - Healthcare showcase

Year Founded & Workforce

2013

2,100 Employees

Industry

Healthcare

Services

Cannabidiol (CBD) OilCannabidiol (CBD) Gels
A

Aphria Inc Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aphria Inc Overview

Company Headquarters: Ontario, Canada

Founded: 2013

Workforce: ~2,100

Company Working: Aphria Inc. is a Canada-based company that provides safe, clean, and pure pharmaceutical-grade cannabis to its customers. The company runs its business through retail and wholesale channels both domestically and internationally. In addition to operating in more than 10 other countries besides Canada, Aphria is a significant supplier of medical cannabis to Germany. Moreover, the company operates as a subsidiary of Tilray, Inc (US) which was acquired in December 2020. It also focuses on the research and development of innovative products and spends a significant amount of revenue on R&D Furthermore, the company is directly present in more than ten countries and has a strong presence in all the established markets such as North America, Europe, Africa, and Australia

Strategy

Aphria Inc. focuses on the development of quality products through research and development. Moreover, it also emphasizes increasing geographic presence through strategic collaborations and agreements. The company operates through its 17 subsidiaries that are present all over the world. In addition, Aphria focused on raising awareness and educating individuals about the benefits of plants, plant gardens, and the impact of plants on collective well-being.

Company Snapshot

$179.3M

Revenue

2,100

Employees

2013

Founded

Ontario, Canada

Headquarters

SWOT Analysis

Strengths

  • Strong brand name
  • Strong regional presence in Europe and North America
  • High quality products
  • Successful track record of launching new products

Weaknesses

  • Limited market presence in Asia-Pacific
  • High dependence on existing supply chain

Opportunities

  • Expansion in untapped regions
  • Leveraging digital technologies

Threats

  • Intense competition
  • Pricing pressure from government in various regions

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
June 2022Product LaunchAphria Inc. a Tilray Medical company, launched sleep oriented CBN night oil for medical cannabis patients in Canada. The product launch swill also aims to expand the portfolio of medicinal cannabis products it provides to customers with various needs
June 2021Product LaunchAphria Inc. a Tilray Medical company, launched Symbios, a complement to the Company’s existing medical brand portfolio in Canada. This new brand was designed to offer medical patients a full comprehensive range of products, including flower, oils, and pre-rolls for their health and wellness regiment, at a better price point
June 2019AgreementAphria Inc. announced an agreement with PAX Labs, Inc. (US) for the designing and development of vaporization devices. This agreement will help the company to develop innovative products and to capture untapped markets.

Product Offering

  • Aphria Inc
    • Cannabidiol (CBD) Oil
    • Cannabidiol (CBD) Gels

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 179.3 Mn in 2019 to USD 513.1 Mn in 2021.
Aphria Inc — By Business Segment
Series (USD Mn)201920202021
Sales179.3405.3513.1
R&D Expenditure1.11.90.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.